» Articles » PMID: 33095960

Evaluation of Physician's Knowledge in Jordan About the ACC/AHA Blood Cholesterol Guidelines

Overview
Publisher Wiley
Specialty General Medicine
Date 2020 Oct 23
PMID 33095960
Citations 4
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Elevated levels of blood lipids are considered a major modifiable risk factor for the development of cardiovascular diseases. The optimal management of dyslipidaemia remains inadequate worldwide. Accordingly, there is an increasing need to evaluate the basis that health care providers are using to control dyslipidaemia.

Aim: To evaluate the awareness of Jordanian physicians about the American College of Cardiology/American Heart Association (ACC/AHA) guidelines for dyslipidaemia management.

Method: A written questionnaire was distributed to 250 physicians from different areas of Jordan during 7 months period (from February 2018 until the end of August 2018). The target population is composed of the following categories: juniors, residents, fellows and consultants who were recruited from private, government and military practice settings. The validated developed questionnaire was distributed by trained medical personnel.

Results: A total of 207 physicians filled and handed back the questionnaire. The response rate was 82.8%. Generally, there was a difference in the level of knowledge between physicians (juniors/ residents/ consultants) while there was no difference between genders or practice settings (private or government). The current study showed that the awareness of physicians in different areas of Jordan regarding the 2013 (ACC/AHA) dyslipidaemia guidelines is suboptimal.

Conclusion: Results indicated low levels of knowledge of 2013 ACC/AHA guidelines for the management of dyslipidaemia among physicians in Jordan. Hence, multiple interventions are needed to be implemented in order to increase the level of awareness among Jordanian physicians.

Citing Articles

The Impact of an Educational Intervention on Enhancing Clinical Knowledge of Physicians and Pharmacists Regarding Statins and Monitoring Parameters: The Experience of a Tertiary Teaching Hospital.

Al-Ashwal F, Syed Sulaiman S, Sheikh Ghadzi S, Harun S, Halboup A, Kubas M Adv Med Educ Pract. 2024; 15:357-368.

PMID: 38707544 PMC: 11069367. DOI: 10.2147/AMEP.S445610.


Knowledge, awareness, and attitude among pharmacists regarding the risk estimation of cardiovascular disease in Jordan: Immersion of lipid-lowering agents.

Rababah A, Ababneh M, Abedalqader N, Altarabsheh S Heliyon. 2023; 9(9):e19288.

PMID: 37674836 PMC: 10477471. DOI: 10.1016/j.heliyon.2023.e19288.


Physicians and pharmacists' clinical knowledge of statin therapy and monitoring parameters, and the barriers to guideline implementation in clinical practice.

Al-Ashwal F, Syed Sulaiman S, Sheikh Ghadzi S, Kubas M, Halboup A PLoS One. 2023; 18(1):e0280432.

PMID: 36662695 PMC: 9858478. DOI: 10.1371/journal.pone.0280432.


Risk assessment of atherosclerotic cardiovascular diseases before statin therapy initiation: Knowledge, attitude, and practice of physicians in Yemen.

Al-Ashwal F, Syed Sulaiman S, Sheikh Ghadzi S, Kubas M, Halboup A PLoS One. 2022; 17(5):e0269002.

PMID: 35617266 PMC: 9135296. DOI: 10.1371/journal.pone.0269002.